The Packaging Barrier Films Market Is Anticipated To Surpass A Valuation Of US$ 13 Bn By The Conclusion Of The Assessment Period In 2027

 

The  packaging barrier films market  is expected to face a number of challenges owing to the coronavirus pandemic as costs of labor, raw materials, power, and transport has increased. On the other hand, while demand for packaging barrier films has fallen marginally, many countries have designated packaging films as essential items, which has proven useful to sustain operations throughout the crisis period.

“Stand-up pouches made from barrier films are rapidly replacing plastic and glass packaging alternatives owing to lower costs and higher convenience levels. Further, packaging barrier films use lesser materials and are lighter than rigid packaging options, thereby boosting adoption and revenues, ”says the FMI analyst.

Request report sample to gain in-depth market insights at  https://www.futuremarketinsights.com/reports/sample/rep-gb-5000

Packaging Barrier Films – Key Takeaways

  • Pharmaceutical applications are anticipated to contribute significantly to revenues, driven by higher investments in healthcare and drug formulations that require protection from contaminants.
  • PET based packaging films are highly sought after owing to superior barrier characteristics against oxygen and water vapor.
  • Asia Pacific is displaying high production and consumption of packaging barrier films owing to extensive pharma and processed food packaging applications.

Packaging Barrier Films – Driving Factors

  • Niche applications of barrier films in packaging of electronic items such as OLED and photovoltaic material generates lucrative opportunities.
  • Cost benefits for end user industries in logistics and material costs are a key factor that drive the adoption of packaging barrier films.

Packaging Barrier Films – Key Constraints

  • Environmental concerns associated with the production and disposal of conventional packaging barrier films hurt market prospects.
  • Lack of adequate recycling facilities and technologies for flexible packaging formats hold back market growth.

The Anticipated Impact of Coronavirus

The coronavirus pandemic will negatively impact the packaging barrier films market owing to high production costs from fluctuating raw material supplies, and shortage of manpower. In addition, the lockdown has caused suspension of production, and disrupted supply chains in the short term. However, the designation of barrier packaging films as essential items, and applications in FMCG sector will help players to sustain operations and partially cut losses during the crisis period.

Explore the global packaging barrier films report with 301 illustrative figures, 310 data tables and the table of contents. You can also find a comprehensive market segmentation on https://www.futuremarketinsights.com/askus/rep-gb-5000

Competition Landscape

Leading players in the packaging barrier films market include but are not limited to KOROZO Ambalaj San.ve Tic A.S, Amcor Ltd., VF Verpackungen GmbH, Bemis Company Inc., Lietpak, Uflex Ltd., Flexopack SA, Sealed Air Corp., Sudpack Verpackungen GmbH & Co. KG, Mondi plc, Supravis Group SA, and Huhtamaki Oyj.

Manufacturers are primarily pushing for circular economy initiatives to set up recycling facilities and developing recyclable or biodegradable packaging barrier film options, to bolster portfolios and meet consumer bias towards eco-friendly products.

For instance, Mondi plc has collaborated with Hutthaler for the development of a completely recyclable, mono-material, thermoforming barrier film for meat packaging applications. Innovia Films has collaborated with Wildcorn for fully recyclable packaging barrier film pouches for its popcorn products. So, Amcor Ltd. has unveiled AmLite, a polyolefin, ultra-recyclable packaging film for food, personal care, and pharma packaging applications.

For More Information or Query or Customization Before Buying, Visit:  https://www.futuremarketinsights.com/customization-available/ rep-gb-5000

Cosmetology Market| One the Most Booming Industry in Upcoming Years Due to Global Demand in Industry by 2027

Cosmetology is the study of beauty, treatments and its applications. There are various branches of specialty in the cosmetology market, i.e. hairstyling, skin care, cosmetics, manicure/pedicure, and others. Cosmetology or Aesthetics is an inclusive term for specialties which focus on improving appearance through cosmetic procedures. Cosmetology market is primarily focused on the increasing demand by the end users, and lowering of pricing for implants and surgeries and high efficiency of the method.

Cosmetology Market: Dynamics

Cosmetology market is driven by new product innovation and new technologies as end users focus on new methods of skin and hair enhancement, healthcare expenditure, rising disposable income, and the emergence of technologically superior products. In addition to this cosmetology market is growing due to the rising awareness among end users towards breast cancer, mastectomy, has also impacted the cosmetology market. However, as the cosmetology market progresses, there are associated risks such as the risk of failure, associated malfunctioning of the implants, high prices of the surgery, regulatory scenario to maintain the standards of the implants used and cosmetic implants. Cosmetology market is also facing significant challenges as the government does not grant reimbursements. Also, not many initiatives are taken by the government of incentives. A major drawback which cosmetology industry faces is that the insurance does not cover the costs of cosmetology procedures.

Request a report sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-4203

Cosmetology market has multiple opportunities such as the development of low-cost implants by major companies.

Cosmetology Market: Region-wise Outlook

Based on geography, the cosmetology market can be segmented into five major regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. At present, North America holds a leading position in the cosmetology market followed by Europe. The major driving factors which have driven the growth of the cosmetology market in these regions are continuously increasing demand from the end users for new methods of enhancements and continuous improvements in the cosmetology market. Following North America, European countries are also anticipated to show steady growth in the cosmetology market. In the next few years, Asia-Pacific would show remarkable growth in the cosmetology market as it is developing at a very rapid pace and has shown the emergence of many regional players. The factors which would fuel the growth of cosmetology market in Asia-Pacific are increasing awareness regarding various medical procedures, increase in the number of key players and rapid development in the healthcare infrastructure across the Asian countries. Cosmetology market would evolve at a rapid rate across the regions, however, North America would maintain its position in the overall cosmetology market.

Cosmetology Market: Key Players

In the past decade, the cosmetology market has witnessed a massive influx of well-established players which provide raw materials in the cosmetology market. Some of the top players operating in the cosmetology market are GC Aesthetics, Mentor Worldwide LLC, Sientra Inc., Zimmer Holdings Inc., 3M Health Care, Allergan, Inc., Implantech Associates Inc., Institut Straumann AG, Nobel Biocare Holding AG, Spectrum Designs Medical, and many others. Cosmetology market has the presence of many regional players which have a huge market share in emerging countries.

Discover more about report analysis with figures and data tables, along with the table of contents. Request for TOC- https://www.futuremarketinsights.com/toc/rep-gb-4203

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

The regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia-Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • The Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request for Pre Book of Report: https://www.futuremarketinsights.com/checkout/4203

Cosmetology Market: Segmentation

Cosmetology market can be segmented by various types of procedures offered for skin care:

  • Surgical
  • Non-Surgical

Cosmetology market has a broad scope due to the various applications of the procedures offered. By the different procedures we can segment the market into the following:

  • Hair transplant
  • Buttock Augmentation and Reduction
  • Breast Augmentation and Reduction
  • Cosmetic Reconstruction
  • Others

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth Polishing / Lapping Film market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

Seasonal Affective Disorder Therapeutics Market Key Players – Sanofi AG, Novartis AG, Janssen Pharmaceuticals, Inc., The Sunbox Company ,Verilux, Inc., Carex Health, Northern Light Technologies

The seasonal affective disorder (SAD) therapeutics market is pegged at around US$ 450 million in 2019, with a modest Y-o-Y increase of 3.9% over 2018, according to a recent intelligence report by Future Market Insights. While drugs and devices collectively contribute to the consumption volume of seasonal affective disorder therapeutics, the latter will remain a major shareholder in the market. Towards the end of 2019, more than 3.4 million devices are likely to be sold globally, in seasonal affective disorder therapeutics market.

[216 Pages Report] It has been noted that physicians across the globe are increasingly recommending Bright Light Therapy (BLT) as a prophylactic measure for Depression and Seasonal Affective Disorder Therapeutics. BLT provides a robust, rapid and completely anti-depressant effect. The light therapy onset should be typically within four days of Seasonal Affective Disorder. Monitoring should be done on a phase resetting basis on timed effects of introduction of bright light.

Popular drugs preferred in seasonal affective disorder therapeutics include selective serotonin reuptake inhibitors (SSRIs), according to the report. While generics and branded drugs are widely available in seasonal affective disorder therapeutics market, Buproban and Citalopram continue to register relatively higher sales. FMI attributes this dominance to high availability of generic versions of the aforementioned drugs.

To remain ‘ahead’ of your competitors, request for a sample

Bright light therapy that has been the most preferred line of treatment in seasonal affective disorder therapeutics continues to receive strong support from physicians and patients owing to positive end results. While more than half the sales of devices used in seasonal affective disorder therapeutics is accounted by light boxes, sales of desk lamps are also thriving at a brisk rate.

A highly recommended prophylactic measure involved in seasonal affective disorder therapeutics, light therapy is characterized by its rapid, reliable, and highly anti-depressant action. Extensive adoption of bright light therapy by the patients afflicted by a sub-syndromal disease and self-reporting patient population prompts at bolstered revenue visibility prospected for seasonal affective disorder treatment therapeutics in coming years.

key players

  • Allergan plc.,
  • Eli Lily Company,
  • GlaxoSmithKline plc,
  • Pfizer Inc.,
  • Teva Pharmaceuticals Inc.,
  • Bausch Health Companies Inc.,
  • F. Hoffmann-La Roche AG, Mylan N.V.,
  • Sanofi AG, Novartis AG,
  • Janssen Pharmaceuticals, Inc.,
  • The Sunbox Company,
  • Verilux, Inc.,
  • Carex Health,
  • Northern Light Technologies,
  • Beurer GmbH and Koninklijke Philips N.V.

seasonal affective disorder therapeutics market

Get a Customized Scope to Match Your Need Ask an Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-8821

Demand for Combination Therapy for SAD Picking Up

The report opines that light therapy is the first line of treatment that seasonal affective disorder therapeutics providers opt for. However, a possible ineffective outcome for certain patients of SAD related psychiatric illnesses and depression creates scope of combination therapies. Some of the recently reported clinical trials emphasize potential efficacy of combination of light therapy, psychotherapy, talk therapy, and antidepressants in seasonal affective disorder therapeutics.

Inaccessibility at workplaces or during traveling has been a shortfall of light box therapy over the years. To help patients suffering from SAD explore non-conventional alternatives to seasonal affective disorder therapeutics, Austria-based med-tech startup, Active Wearables, recently launched a wearable device – Pocket Sky – providing light therapy, practically anywhere. The wearable has a wireless charging feature and the battery life is claimed to last for a couple of weeks. The Pocket Sky will potentially serve as a portable and lightweight light therapy solution to patients of seasonal affective disorder. Such innovations will continue to innovate the seasonal affective disorder therapeutics market landscape.

Inadequate availability of research data and ineffective documentation, especially related to use of bright light and blue light in light therapy, is posing a long-term challenge to rapid revenue growth of seasonal affective disorder therapeutics market. Moreover, proven adversities associated with excessive use of antidepressants also remain a concern among physicians and patients alike, limiting healthy growth prospects of seasonal affective disorder therapeutics market.

The report tracks performance of global seasonal affective therapeutics market over 2018-2028. In-depth strategic profiles of some of the leading players have been covered in the report, including Allergan plc, Eli Lily Company, GlaxoSmithKline plc, Pfizer Inc., Teva Pharmaceuticals Inc., F. Hoffmann-La Roche AG, Sanofi AG, Novartis AG, Janssen Pharmaceuticals, Inc., and Koninklijke Philips N.V. among others.

For more insights on global seasonal affective disorder therapeutics market through 2028, write in to press@futuremarketinsights.com

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-8821

Key Segment

based on treatment type

  • light boxes
  • dawn stimulators
  • desk lamps
  • sun visors

based on disorder type

  • SSRIs
  • SNRIs
  • NDRIs
  • TCAs
  • MOAIs

based on Distribution channel

  • institutional sales
  • retail sales

based on regions

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania and MEA

Glass Bottles Market 2022 Industry Research, Segmentation, Key Players Analysis And Forecast To 2031

As per a study by FMI, the glass bottles sales are expected total US$4.8 bn through 2031, growing at a CAGR of 5.2% over the forecast period of 2021 to 2031. The market witnessed a rise of 3% CAGR during its historical sales period between 2016 and 2020.

According to a study by FMI, the glass bottles market worth will reach US$37.1 bn in 2021. After battling a slight dip of sales during COVID-19 outbreak, the sales grew by 1% year-on-year in 2021.

Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-5122

Glass bottles are 100% recyclable, which makes them better alternative to plastic bottle form the environmental point of view. With focus on sustainability rising at a high pace, glass bottles sales will continue rising through the assessment period.

As per FMI, sales in the U.S. will rise considerably. Ban on single-use plastic and other policies undertaken to protect environment will create a conducive environment for increasing glass bottle sales in the country. Besides this, demand in China will continue surging, pushing growth in East Asia.

While glass bottle application is increasing across diverse industries, the food and beverages sector will account for over half of the market share. Increasing use of glass bottles in beverage packaging will continue driving sales. Demand in pharmaceutical sector also is expected to rise in the coming years.

Get Access to Research Methodology Prepared by Experts>>> https://www.futuremarketinsights.com/ask-question/rep-gb-5122

“Innovations remain key focus for market players. From launch of long-neck beer bottles to ensuring greater agility, manufacturers are leaving no stone unturned to cater to the changing consumer preference,” says the FMI analyst.

Key Takeaways

  • The U.S. is expected to lead the global market as it holds 84% market shares in North America. Consumers in this country prefer and consume glass bottles for alcoholic beverages. The ban on single use plastic is also another factor boosting demand in the market.
  • Germany holds 25% of the Europe market as it has some of the oldest and largest pharmaceutical companies in the world. The usage of glass bottles in Germany is majorly driven by pharmaceutical application.
  • India holds 39% market shares in South-Asia as this country is the second largest consumer and producer of glass bottles in the region.
  • Type I grade glass bottles hold 51% of the market and are expected to register high demand due to extensive application in pharmaceutical industry.
  • Glass bottles with capacity of 501-1000ml hold 36% market share as they are primarily used for storing and transporting water, fruit juices, and milk.

Key Drivers

  • Rising trend for sustainable, bio-degradable materials in packaging industry is expected to boost demand for glass bottles in the market.
  • Glass bottles are becoming the ideal packaging material for food and beverage application therefore boosting its demand in the F&B industry.

Key Restrains

  • COVID-19 crisis has impacted the production and manufacturing of glass bottles due to lockdown and disrupted supply chain.
  • Shutdown of numerous end-use industries is also expected to hamper demand for glass bottles in the global market.

For More Information or Query or Customization Before Buying, Visit: https://www.futuremarketinsights.com/customization-available/rep-gb-5122

Competitive Landscape

The global glass bottles market is moderately fragmented in nature. Key players in the market are focusing on increasing production and investing in product development. Innovation for improved, sustainable products will keep players ahead in the competition.

For instance, in June 2021, AB InBev announced about the launch of a lightweight longneck beer bottle for commercial applications. Several other companies are expected to focus on product launches spurring growth in the market.

Key players operating in the glass bottles market profiled by FMI includes

  • Owen Illinois, Inc.
  • Ardagh Group, SA
  • Vitro, S. A. B. de C. V.
  • Vidrala, S.A
  • BA Glass B.V.
  • AGI Glasspack Limited.
  • Frigoglass Jebel Ali FZCO
  • Consol Glass (Pty) Ltd.
  • Toyo Glass Co., Ltd.
  • Gerresheimer AG
  • Vetropack Holding AG
  • Borosil Glass Works Ltd.
  • Carib Glassworks Limited (CGL)
  • Piramal Glass Private Limited
  • Albéa S.A.
  • Verallia SA
  • Stölzle-Oberglas GmbH
  • Gallo Glass Company
  • Allied Glass Containers Ltd
  • SGA S.A.

More Insights on the Glass Bottles Market:

FMI provides an unbiased analysis of the glass bottles market, presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the global glass bottles market with a detailed segmentation on the basis of:

By Grade:

  • Type I
  • Type II
  • Type III

By Manufacturing Process:

  • Blown
  • Tubing

By Capacity:

  • Up to 50 ml
  • 51 – 200 ml
  • 201 – 500 ml
  • 501 – 1000 ml
  • 1001 ml & Above

By End User:

  • Food
  • Beverages
  • Pharmaceuticals
  • Personal Care & Cosmetics
  • Perfume & Fragrances
  • Chemicals
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/5122

Key Questions Covered in the Benign Prostatic Hyperplasia Treatment Market Report 

  • The report offers detailed insights into glass bottles demand outlook for 2021-2031
  • The market study also highlights projected sales growth for glass bottles market between 2021 and 2031
  • Glass bottles market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends, evaluation of current market size, and technological advancements within the industry
  • Glass bottles market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others

Zipper Pouch Demand To Improve By 4.2% In 2022 Reaching Volume Of 44.3 Billion Units

Zipper Pouch Market Snapshot

Newly released data by Future Market Insights (FMI), predicts the zipper pouch demand to improve by 4.2% in 2021 reaching volume of 44.3 billion units.

The overall valuation is expected to top US$ 2.1 billion in 2021, with the market continues exhibiting growth at a CAGR of 5.3% between 2021 and 2031. Rising in-store sales will remain a chief growth driver as consumers show greater keenness for competently packaged food items.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4773

While improvement is global sales is on cards, developed countries are expected to remain primary markets. Against this backdrop, FMI predicts demand in North America to surpass US$ 543.3 million in 2021. The U.S. will emerge as a highly lucrative pocket for sales within North America, exhibiting 4.1% year on year growth in the same year.

Zipper pouches are accepted worldwide because they are both re-sealable and re-usable. These products also offer strong barriers to external atmosphere and temperature fluctuations. Applications of zipper pouches in the pharmaceutical, cosmetics, and personal care industries are gaining traction.

Marketers and retailers are able leverage zipper pouches to fulfil demand for packaging aesthetics. Also, consumer convenience through clear packaging attributes is likely to fuel demand for the foreseeable future.

In recent years, manufacturing giants have shifted their focus on the use of recyclable raw materials such as polyethylene (PE), polyvinyl chloride (PVC) and polypropylene (PP). Improvements in machinery have enabled large scale production with minimal waste.

Largely, the zipper pouch market is projected to grow supported by the usage of sustainable materials and green practices by producers and end-use industries.

For More Information or Query or Customization Before Buying, Visit: https://www.futuremarketinsights.com/customization-available/rep-gb-4773

Key Takeaways from the Zipper Pouch Market

Study Stand up zipper pouches account for more than 79% market value, owing to relative ease of use. In North America, the U.S. holds a market share of almost 89% in 2021, driven by a matured packaged food sector. The zipper pouch market in Germany is anticipated to exhibit a growth rate of 5% supported by the large-scale manufacturing sector of the country. India is a fast-growing market in APEJ, driven by a large consumer base and changing consumer food and beverage consumption trends. Zipper pouches are most widely used packaging various types of food products, as it holds almost 76% of market share in the year 2021.

“Expansion of the global zipper pouch market is largely driven by a surge in demand for packaged foods. The need to preserve food items and offer protection against harsh atmospheric conditions have aided developments in the industry. Most manufacturers are focusing eco-friendly raw materials and sustainable practices for producing making zipper pouches” says the FMI analyst.

Zipper Pouch Market Landscape

Key players contribute 20-30% of the global market. Market leaders are largely engaged in strategies to expand production capacity while investing in material innovations to improve on packaging barrier properties.

Berry Global Group, Amcor plc and Rengo Co. Ltd., Transcontinental Inc., C.I. Takiron Corporation and Novolex Holdings, LLC are some of the leading players in the zipper pouch market.

For Information On The Research Approach Used In The Report, Ask Analyst @ https://www.futuremarketinsights.com/askus/rep-gb-4773

Zipper Pouch Market Report

Future Market Insights, in its new report, offers an unbiased analysis of the zipper pouch market, analyzing historical demand from 2012-2020 and forecast statistics for 2021-2031. The study reveals growth projections on the zipper pouch market on the basis of product type (standup zipper pouch and flat zipper pouch), material type (plastic, aluminum laminates, paper, and others), end use (food, pharmaceuticals, cosmetics & personal care, and others) and the closure type (slider zip and press to close) across seven regions.

Europe Viscosupplementation Market Is Expected To Expand At A CAGR Of 5.1% Over The Forecast to 2021–2026

Future Market Insights (FMI) delivers key insights on the Europe viscosupplementation market in its upcoming report titled, “Viscosupplementation Market: Europe Industry Analysis and Opportunity Assessment, 2016-2026”. In terms of revenue, the Europe viscosupplementation market is projected to register a healthy CAGR of 5.1% during 2016-2026.

FMI’s report has segmented the market on the basis of product type, end user and region.

Based on product type, the market has been segmented into one injection viscosupplementation, three injection viscosupplementation and five injection viscosupplementation.

Single injection viscosupplementation product type segment is expected to emerge as the most popular segment over the forecast period, driven by better patient compliance as the treatment reduces the need for multiple hospital visits. The segment is expected to register the highest CAGR of 6.7% during the forecast period.

To remain ‘ahead’ of your competitors, request for a sample

Five injection viscosupplementation product type segment is expected to witness a decline in market share in terms of revenue from 29.0% in 2015 to 23.3% in 2026. This decline is attributed to more incidence of side effects and repeated patient visit requirements associated with five injection viscosupplementation. Reimbursement cutbacks and high injection costs are other factors that can curtail demand for five injection viscosupplementation.

By end-users, the market is segmented into hospitals, ambulatory surgical centres and orthopaedic clinics. Hospitals end-use segment is expected to witness significant demand for viscosupplementation, registering a CAGR of 4.3% over the forecast period. Better reimbursement options and increasing patient preference for single injection cycle for osteoarthritis treatment is expected to drive demand for one injection viscosupplementation in the orthopaedic clinics segment over the forecast period.

 

europe-viscosupplementation-market

Europe Viscosupplementation Market Trends

Key trends in the viscosupplementation market are the use of single injection cycle for osteoarthritis treatment and introduction of new combination products in the market. For example, the product pipeline of major players in the viscosupplementation market involves combining corticosteroid injections, which help in relieving pain associated with osteoarthritis, with long-lasting effects of hyaluronic acid, which lasts for nearly six months. Further, regional competition within EU countries, especially in five injection cycle, is leading to entry of new market players. Europe is a mature market in terms of generic products and it is therefore relatively easier to obtain CE mark in Europe than it is to obtain the U.S. FDA approval.

Western Europe has been estimated to dominate the Europe viscosupplementation market in 2015, attributed to factors such as the presence of key regional players, strong distribution network and better healthcare infrastructure in the region.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-eu-1383

Key Players in Europe Viscosupplementation Market

  • Anika Therapeutics Inc.
  • Sanofi S.A.
  • Zimmer Biomet Holdings
  • Meda AB
  • Ferring B.V
  • Fidia Pharmaceutici S.p.A
  • Bioventus LLC.

We have discussed individual strategies followed by these companies in terms of enhancing product designs, creating new manufacturing facilities, market consolidation and advanced R&D initiatives. The report concludes with key takeaways that could help players already present in the market and new players planning to enter the market in the long run.

Market Dynamics

Growth of the Europe viscosupplementation market is mainly driven by rising obesity rates and growing patient awareness about effective treatment therapies for knee osteoarthritis, coupled with macroeconomic factors such as high unmet patient needs and strengthening of distribution network by key players in the viscosupplementation market.  Other prominent growth drivers include rapidly growing medical technology industry and cost-effectiveness of the treatment. However, economic issues in some Eastern European countries and reimbursement cutbacks are expected to hamper overall growth of the viscosupplementation market in Europe over the forecast period.

Viscosupplementation devices are classified under Class III category in Europe and are considered high-risk devices. They require premarket approval from notified bodies, including private organisations recognised by the European Free Trade Association (EFTA).

Key Segments

  • Product Type
    • Single Injection Viscosupplementation
    • Three Injection Viscosupplementation
    • Five Injection Viscosupplementation
  • End User
    • Hospitals
    • Ambulatory Surgical Centres
    • Orthopaedic Clinics

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-eu-1383

 Key Regions/Countries

  • Western Europe
    • U.K.
    • France
    • Germany
    • Spain
    • Italy
    • Nordics
    • Rest of Western Europe
  • Eastern Europe
    • Russia
    • Rest of Eastern Europe

Molecular Imaging Market Will Expand At An Impressive CAGR Of Around 11.3% From 2021 To 2031

Molecular imaging is an emerging diagnostic technology that allows visualization, differentiation, and quantify various biological processes occurring inside a living organism at the molecular and cellular level. The global molecular imaging market is estimated to be valued approximately at US$ 4 Bn in 2021, finds Future Market Insights (FMI) in a study.

Clinical molecular imaging is trending towards hybrid modalities such as PET-CT, SPECT, or PET-MR that provide high-resolution anatomical imaging. PET-CT is anticipated to gain maximum revenue share over the forecast period, and the segment is projected to expand at a CAGR of 16.3% during the forecast period.

Molecular imaging targets molecular pathways and mechanisms associated with a particular disease present inside a living body. It enables to study of the molecular abnormalities taking place inside the body to carry out early detection of disease and to optimize medications aiming for disease-related molecular targets. Nuclear medicine plays a vital role in conducting a molecular imaging process and can be broadly used for the treatment of distinct cancer and related diseases.

Molecular imaging has evolved as a promising tool for early detection of cancers and cardiac diseases, providing a more complete picture of the tumor genome, as well as monitoring tumor emergence during disease. Molecular imaging provides the ability to accurately evaluate biological responses to the treatment of individual patients over time, opening the door to personalized medical techniques directed by molecular imaging reporters.

To remain ‘ahead’ of your competitors, request for a sample

Key Takeaways from Molecular Imaging Market Study

  • Molecular imaging market will register accelerating demand, enabling a y-o-y growth of nearly 11% in 2021
  • Backed by presence of a state-of-the-art healthcare infrastructure, the U.S. accounts for nearly 65% sales in North America
  • Driven by rising cases of cancer, the  U.K. market will exhibit above 14% y-o-y growth in 2021
  • Government initiatives aimed at offering advanced medical care will enable growth in Germany and France
  • The market in China is expected to surge at a CAGR of over 10% from 2021 to 2031

 “Increasing research & development activities in cancer-specific drug discovery and other chronic diseases are expected to boost demand for molecular imaging. Besides this, as a result of increasing incidence of cancer the demand for highly sensitive and precise diagnostic for better treatment solutions is increasing,” says a Future Market Insights analyst.

molecular imaging market region wise plc position and notable trends, 2021

Molecular Imaging Needs Rising In Response to Increasing Cancer Cases

According to the World Health Organization (WHO) in 2020, breast cancer emerged as the most common type of cancer, affecting 2.2 million people around the world.  Lung cancer has been the leading cause of death with over 1.7 Mn of total deaths in 2020. North America has the highest incidence rate of cancer followed by East Asia. This rise in the cancer population is leading to a rise in the demand for diagnostic imaging, thereby catalyzing the demand for molecular imaging.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-724

Who is Winning?

Key players in the molecular imaging market are keenly focusing on carrying out strategic activities such as acquisitions, collaborations, and mergers, product launch, global expansion to create a strong position in the market is leading to vigorous developments which are helping the market to grow at a considerable rate.

For instance, in 2019, Bruker Corporation launched a benchtop magnetic resonance spectrometer with a high-field 9.4 Tesla small animal MRI system with integrated in-line PET. Thus strengthening its product portfolio.

Strategies adopted by key players are often intended at global expansion. They largely  focus on product launches and mergers & acquisitions. There have been a few strategic partnerships among leading players to enhance the product line and better facilities for end-user.

In September 2020, Bruker Corporation announced the acquisition of Canopy Biosciences, LLC. This acquisition enhances Bruker’s offering in targeted multi-omics and fluorescence-based imaging techniques.

Some of the key players are Key market players covered by Future Market Insights in the report are :

  • Hermes Medical Solutions
  • Bruker Corporation
  • GE Company
  • Fujifilm Holdings Corp.
  • Koninklijke Philips N.V.
  • Siemens AG
  • Toshiba Medical System Corp.
  • Mirada Medical Limited
  • Carestream Health, Inc.
  • Esaote SpA,
  • Positron Corporation,
  • Medisco Ltd.
  • Hitachi Medical Corp.
  • MIM Software Inc.

Molecular Imaging Market by Category 

Modality

  • Positron Emission Tomography (PET)
  • Positron Emission Tomography- Computed Tomography (PET-CT)
  • Positron Emission Tomography- Magnetic Resonance (PET-MR)
  • Single Photon Emission Computed Tomography (SPECT)
  • Software
    • On Premises Solutions
    • Cloud Based Solutions
  • Magnetic Resonance
  • Molecular Ultrasound Imaging

Application

  • Cardiology
  • Oncology
  • Gastrointestinal Disorders
  • Neurology Disorders
  • Others

 End User

  • Hospitals
    • 500+ Beds
    • 200-499 Beds
    • Less than 200 Beds
  • Ambulatory Surgical Centres
  • Diagnostic Centres

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-724

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • MEA

The Laminated Tubes Market Is Expected To Reach US$ 1.8 Bn By 2031, Growing At A CAGR Of 6.3% For 2020- 2031

The laminated tubes market revenue totaled US$ 940 Mn in 2020, according to Future Market Insights (FMI). The overall laminated tubes market is expected to reach US$ 1.8 Bn by 2031, growing at a CAGR of 6.3% for 2020- 31.

FMI has projected competition in the market to continue soaring through the assessment period. The top 5 market players are expected to hold 20%-25% of the global laminated tubes market in 2021.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4301

2012-2020 Laminated Tubes Market Outlook Compared to 2021-2031 Forecast

As per FMI analysis, the global laminated tubes market revenue is likely to double over the next decade. This growth is attributed to the expansion of the oral care industry.

Laminated tubes are gaining traction since the past three years as these tubes offer combined positive aspects of plastic and metals. Laminated tubes were primarily used for the packaging of high-volume products such as toothpaste. However, now these tubes have applications across varying sectors, from adhesives and acrylic oil paints to cosmetic and pharmaceutical products.

The surging scope of application of laminated tubes can be attributed to their tough barrier resistance. The plastic material used in the laminated tubes has barrier strength close to those of alumina. Because of the same, laminated tubes limit the contact of air with the stored product with air, moisture, and strong light, which might deteriorate the quality of the product and make it useless. On the back of this, the consumption of laminated tubes at the global level is expected to double in comparison to in the past decade.

For More Information or Query or Customization Before Buying, Visit: https://www.futuremarketinsights.com/customization-available/rep-gb-4301

Key Takeaways from Laminated Tubes Market

  • Laminated tubes are made from multiple layers of different materials of EVOH, aluminum, and plastic. Of these, the demand for aluminum barrier laminate (ABL) is highest. FMI also projects the ABL segment to account for 82.2% of the market by 2031.
  • The 50 to 100 ml capacity segment will account for 62.4% market share by 2031. These type of tubes are designed as a standard size preferred by the consumers, primarily used for cosmetics and oral care packaging
  • Stand-up caps are more preferred in the laminated tube and are expected to hold 45.1% of market share by 2031.
  • The oral care segment is projected to be the fastest-growing end-user segment, accounting for 45.3% of sales through the forecast period.
  • East Asia market is expected to show strong  growth, rising at 8.1% CAGR during the forecast period of 2021-2031.

 “With increasing consumer focus on oral hygiene and a shift in preference towards visually appealing, hygienic, and premium quality cosmetic products are creating opportunities for laminated tubes market growth. These trends also are encouraging manufacturers to focus on innovations to offer more efficient packaging solutions,” says FMI analyst.

Demand in Beauty and Personal Care Industry to Increase

Consumers have become increasingly concerned about the quality and brand value of the cosmetics and personal care products they purchase. Willingness to spend on quality products with premium packaging that will prevent contamination of product packed inside and improve their shelf-life will increase laminated tubes application in the cosmetics sector.

The trend of glossy tubes with sophisticated metallic effects and intricate designs such as realistic photo prints, matte or glossy finishes will help laminated tubes to stand out in the competition.

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/askus/rep-gb-4301

Competitive Landscape

Companies operating in the laminated tubes market are aiming at strategic partnerships with other manufacturers to expand their product manufacturing capabilities and product portfolio, besides focusing on sustainability and innovation. For instance:

  • In March 2021, Independent authority, RecyClass certified Huhtamaki blueloop laminate tubes to be fully recyclable.
  • In December 2020, , Hoffman Neopac AG introduced Europe’s first mono-layer barrier tubes to receive product approval and full RecyClass Technology
  • In June 2021, Erpro 3D and Albea S.A. factory joined a partnership to drive innovation in cosmetics with industry leader HP Multi Jet Fusion 3D printing technology.
  • In June 2021, EPL Limited is partnered with Uniliver to achieve sustainability in the oral care segment. The EPL Ltd. will supply Unilever APR approved fully sustainable and 100% recyclable toothpaste category Platina Tubes. The EPL Ltd. companies Platina Tube are entirely recyclable and fully sustainable tubes accredited by APR (The Association of Plastic Recyclers)

Diabetic Macular Edema Market Key Players – Novartis AG, Bayer AG, Allergan Plc., F. Hoffman-La Roche Ltd., Alimera Sciences Inc.

The global diabetic macular edema (DME) market is projected to register a sluggish expansion at 1.1% CAGR through 2027, according to a report by Future Market Insights (FMI). The report estimates the market to reach US$ 3710.2 Mn in 2017; by 2027 this number is expected to surpass US$ 4,000 Mn.

An Uptake of Intravitreal Implants by Patients to Drive Growth of the Market in North America

North America will remain dominant in the global diabetic macular edema market. An uptake of intravitreal implants by new as well as existing patients, who do not show any improvement post-treatment with intravitreal injections, is expected to sustain growth of the market in this region.

Although control of diabetes is a health priority in developed North American countries, such as the U.S., less attention is given to DME management, with diabetes-related caregivers tending to focus on treatment of diabetic complications. A major reason behind this is lack of effective treatment for DME in North America. In addition, an error exists between industry sponsored and independently run clinical trials. Most of the independent clinical trials for DME treatment lack long-term results pertaining to safety and efficacy of new combination therapies for DME. These factors are likely to inhibit growth of the market in North America.

To remain ‘ahead’ of your competitors, request for a sample 

Diabetic Macular Edema Market in Western Europe to Register the Highest CAGR through 2027

The diabetic macular edema market in Western Europe is expected to register a comparatively higher CAGR than other region segments through 2027. Pharmaceutical companies in this region are making substantial investments in research and development, new technologies, and infrastructure in order to capture a market share in the surging burden of eye diseases. This is expected to retain growth of the market in Western Europe.

However, patients in Western Europe resist the intake of intravitreal injections of anti-VEGF drugs, which leads to an instant increase in intraocular pressure causing severe pain in the head or eyes. This a major factor impeding growth of the diabetic macular edema market in Western Europe.

Anti-VEGF will Remain Preferred Product in the Global Diabetic Macular Edema Market

Anti-VEGF will remain preferred product in the market, with sales estimated to expand at 1% CAGR through 2027. Eylea will continue to be the most lucrative anti-VEGF drug in the market. However, demand for corticosteroids will remain comparatively lower than anti-VEGF during the forecast period.

By product form, intravitreal injections will continue to be sought-after in the market, with sales poised to surpass US$ 4,000 Mn by 2027-end. Sales of intravitreal implants will register a comparatively higher CAGR than intravitreal injections through 2027.

Hospital pharmacy is estimated to remain the largest distribution channel in the market, as majority of countries across the globe dispense intravitreal injections and implants to outpatients by hospital pharmacies. Retail pharmacy, which mainly provides aliquots of off-label indications such as Avastin prescription, will register a comparatively low CAGR than hospital pharmacy in the market through 2027.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-2697

Key market players identified in FMI’s report include:

  • Novartis AG,
  • Bayer AG,
  • Allergan Plc., F.
  • Hoffman-La Roche Ltd.,
  • Alimera Sciences Inc.,
  • Valeant Pharmaceuticals International, Inc. (Bausch & Lomb Inc.)

Key Segment

By Therapy Type

  • Anti-VEGF
    • Ranibizumab (Lucentis)
    • Afilbercept (Eylea)
  • Corticosteroids
    • Fluocinolone Acetonide (Iluvien)
    • Dexamethasone (Ozurdex)
  • Other Off-label Drugs (Triamcinolone Acetonide, Bevacizumab and Pegaptanib)

By Product Form

  • Intravitreal Injections
  • Intravitreal Implants

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-2697

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • MEA

The Packaging Barrier Films Market Is Anticipated To Surpass A Valuation Of US$ 13 Bn By The Conclusion Of The Assessment Period In 2027

The  packaging barrier films market  is expected to face a number of challenges owing to the coronavirus pandemic as costs of labor, raw materials, power, and transport has increased. On the other hand, while demand for packaging barrier films has fallen marginally, many countries have designated packaging films as essential items, which has proven useful to sustain operations throughout the crisis period.

“Stand-up pouches made from barrier films are rapidly replacing plastic and glass packaging alternatives owing to lower costs and higher convenience levels. Further, packaging barrier films use lesser materials and are lighter than rigid packaging options, thereby boosting adoption and revenues, ”says the FMI analyst.

Request report sample to gain in-depth market insights at  https://www.futuremarketinsights.com/reports/sample/rep-gb-5000

Packaging Barrier Films – Key Takeaways

  • Pharmaceutical applications are anticipated to contribute significantly to revenues, driven by higher investments in healthcare and drug formulations that require protection from contaminants.
  • PET based packaging films are highly sought after owing to superior barrier characteristics against oxygen and water vapor.
  • Asia Pacific is displaying high production and consumption of packaging barrier films owing to extensive pharma and processed food packaging applications.

Packaging Barrier Films – Driving Factors

  • Niche applications of barrier films in packaging of electronic items such as OLED and photovoltaic material generates lucrative opportunities.
  • Cost benefits for end user industries in logistics and material costs are a key factor that drive the adoption of packaging barrier films.

Packaging Barrier Films – Key Constraints

  • Environmental concerns associated with the production and disposal of conventional packaging barrier films hurt market prospects.
  • Lack of adequate recycling facilities and technologies for flexible packaging formats hold back market growth.

The Anticipated Impact of Coronavirus

The coronavirus pandemic will negatively impact the packaging barrier films market owing to high production costs from fluctuating raw material supplies, and shortage of manpower. In addition, the lockdown has caused suspension of production, and disrupted supply chains in the short term. However, the designation of barrier packaging films as essential items, and applications in FMCG sector will help players to sustain operations and partially cut losses during the crisis period.

Explore the global packaging barrier films report with 301 illustrative figures, 310 data tables and the table of contents. You can also find a comprehensive market segmentation on https://www.futuremarketinsights.com/askus/rep-gb-5000

Competition Landscape

Leading players in the packaging barrier films market include but are not limited to KOROZO Ambalaj San.ve Tic A.S, Amcor Ltd., VF Verpackungen GmbH, Bemis Company Inc., Lietpak, Uflex Ltd., Flexopack SA, Sealed Air Corp., Sudpack Verpackungen GmbH & Co. KG, Mondi plc, Supravis Group SA, and Huhtamaki Oyj.

Manufacturers are primarily pushing for circular economy initiatives to set up recycling facilities and developing recyclable or biodegradable packaging barrier film options, to bolster portfolios and meet consumer bias towards eco-friendly products.

For instance, Mondi plc has collaborated with Hutthaler for the development of a completely recyclable, mono-material, thermoforming barrier film for meat packaging applications. Innovia Films has collaborated with Wildcorn for fully recyclable packaging barrier film pouches for its popcorn products. So, Amcor Ltd. has unveiled AmLite, a polyolefin, ultra-recyclable packaging film for food, personal care, and pharma packaging applications.

For More Information or Query or Customization Before Buying, Visit:  https://www.futuremarketinsights.com/customization-available/ rep-gb-5000